SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-507511
Filing Date
2012-12-19
Accepted
2012-12-19 09:01:07
Documents
5
Period of Report
2012-12-18
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d455435d8k.htm 8-K 26594
2 CERTIFICATE OF AMENDMENT TO THE COMPANY'S RESTATED CERTIFICATE OF INCORPORATION d455435dex31.htm EX-3.1 6886
3 AMENDED AND RESTATED BYLAWS OF THE COMPANY d455435dex32.htm EX-3.2 55198
4 PRESS RELEASE d455435dex991.htm EX-99.1 8319
5 GRAPHIC g455435g94w42.jpg GRAPHIC 3264
  Complete submission text file 0001193125-12-507511.txt   103061
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 121273141
SIC: 2834 Pharmaceutical Preparations